June 30, 2020 / 9:15 PM / 11 days ago

BRIEF-Matinas Biopharma Resumes Enrollment In The Enhance-It And Enact Clinical Trials

June 30 (Reuters) - Matinas BioPharma Holdings Inc:

* MATINAS BIOPHARMA RESUMES ENROLLMENT IN THE ENHANCE-IT AND ENACT CLINICAL TRIALS

* MATINAS BIOPHARMA - TOPLINE DATA FROM ENHANCE-IT STUDY OF MAT9001 VERSUS. VASCEPA EXPECTED IN Q1 2021

* MATINAS BIOPHARMA - ENACT REMAINS ON TRACK FOR COHORT PROGRESSION IN Q4 2020

* MATINAS BIOPHARMA - EXPECTS TO COMPLETE ENROLLMENT IN ENHANCE-IT STUDY IN AUGUST OF 2020 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below